药效评价Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist.
期刊:Journal of medicinal chemistry发表年份:2010作者:Colin P Leslie; Matteo Biagetti; Silvia Bison; Steven M Bromidge; Romano Di Fabio; Daniele Donati; Alessandro Falchi; Martine J Garnier; Albert Jaxa-Chamiec; Gary Manchee; Giancarlo Merlo; Domenica A Pizzi; Luigi P Stasi; Jessica Tibasco; Antonio Von
